The FDA has set out specific clinical benchmarks for drug approval for NASH
Semaglutide helps reduce your appetite and promote satiety by slowing the emptying of your stomach contents
GLP-1RAs have certain side effects, mostly involving the gastrointestinal system, including nausea (the most frequently reported side effect), diarrhea, constipation, dyspepsia, and vomiting [103]
Navigating weight loss: When to consider bariatric surgery after GLP-1 therapy People who have used GLP-1 medications better known by their brand names like Ozempic, Mounjaro or Wegovy have likely seen meaningful changes in their health, such as improved blood sugar, lower blood pressure and weight loss
The Phase II trial for retatrutide reported some adverse events: A large percentage of participants (73% to 94%) reported side effects while taking retatrutide, especially in the higher 8-mg and 12-mg groups
This carefully structured approach helps minimize side effects while maximizing weight management benefits